Skip to main content
. 2016 Sep 15;11(9):e0159612. doi: 10.1371/journal.pone.0159612

Fig 2. Immunohistochemistry of receptor activator of nuclear factor κB (RANK) in liver.

Fig 2

(A) Representative staining images from patients with PBC, AIH, CHB, PSC and unaffected controls (HC) are shown; (B) Statistical analysis of expressed RANKL in liver. (**, p<0.01; ***, p<0.001).